These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3497884)

  • 1. Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies.
    Barr IG; MacDonald HR; Buchegger F; von Fliedner V
    Int J Cancer; 1987 Sep; 40(3):423-9. PubMed ID: 3497884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retargeting of cytolytic T lymphocytes by heteroaggregated (bispecific) antibodies.
    Barr IG; Buchegger F; MacDonald HR; Carrel S; von Fliedner V
    Cancer Detect Prev; 1988; 12(1-6):439-50. PubMed ID: 3263199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components.
    Mezzanzanica D; Canevari S; Ménard S; Pupa SM; Tagliabue E; Lanzavecchia A; Colnaghi MI
    Int J Cancer; 1988 Apr; 41(4):609-15. PubMed ID: 3258590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.
    Nisticò P; Mortarini R; De Monte LB; Mazzocchi A; Mariani M; Malavasi F; Parmiani G; Natali PG; Anichini A
    J Clin Invest; 1992 Sep; 90(3):1093-9. PubMed ID: 1387883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-targeting of human lymphocytes expressing the T-cell receptor gamma/delta to ovarian carcinoma cells by the use of bispecific monoclonal antibodies.
    Ferrini S; Prigione I; Mammoliti S; Colnaghi MI; Ménard S; Moretta A; Moretta L
    Int J Cancer; 1989 Aug; 44(2):245-50. PubMed ID: 2527207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid antibody-mediated lysis of virus-infected cells.
    Staerz UD; Yewdell JW; Bevan MJ
    Eur J Immunol; 1987 Apr; 17(4):571-4. PubMed ID: 3494618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
    J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
    Weiner GJ; Hillstrom JR
    J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells.
    Pupa SM; Canevari S; Fontanelli R; Ménard S; Mezzanzanica D; Lanzavecchia A; Colnaghi MI
    Int J Cancer; 1988 Sep; 42(3):455-9. PubMed ID: 2971021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with bispecific antibodies.
    Thielemans KM
    Verh K Acad Geneeskd Belg; 1995; 57(3):229-47; discussion 247-8. PubMed ID: 7483816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.
    Kranz DM; Tonegawa S; Eisen HN
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7922-6. PubMed ID: 6334855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells.
    Cho BK; Roy EJ; Patrick TA; Kranz DM
    Bioconjug Chem; 1997; 8(3):338-46. PubMed ID: 9177839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retargeting of T-cell-receptor gamma/delta+ lymphocytes against tumor cells by bispecific monoclonal antibodies. Induction of cytolytic activity and lymphokine production.
    Ferrini S; Prigione I; Mammoliti S; Colnaghi MI; Menard S; Moretta A; Moretta L
    Int J Cancer Suppl; 1989; 4():53-5. PubMed ID: 2530184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of the T-cell antigen-specific receptor and its potential role in lectin-mediated cytotoxicity.
    Hubbard SC; Kranz DM; Longmore GD; Sitkovsky MV; Eisen HN
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1852-6. PubMed ID: 3081904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
    Pircher H; Hämmerling G; Hengartner H
    Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor.
    Wilson A; Shortman K
    Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.